Prognosis of nsclc. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Tumor Cells, Cultured Mediastinum Lymph Nodes Lung Neoplastic Cells, Circulating Chromosomes, Human, Pair 3 Heterografts

Organisms2

Mice, Nude Mice, SCID

Diseases53

Adenocarcinoma Carcinoma, Large Cell Carcinoma, Squamous Cell Lymphatic Metastasis Disease Progression Neoplasm Invasiveness Neoplasm Recurrence, Local Breast Neoplasms Carcinoma, Small Cell Adenocarcinoma, Bronchiolo-Alveolar Brain Neoplasms Lung Neoplasms Recurrence Liver Neoplasms Neoplasm Metastasis Carcinoma Stomach Neoplasms Colorectal Neoplasms Carcinoma, Hepatocellular Neovascularization, Pathologic Carcinoma, Adenosquamous Neoplasms Small Cell Lung Carcinoma Esophageal Neoplasms Melanoma Ovarian Neoplasms Pancreatic Neoplasms Acute Disease Bone Neoplasms Heart Failure Radiation Pneumonitis Adenocarcinoma, Mucinous Carcinoma, Non-Small-Cell Lung Myocardial Infarction Chromosome Aberrations Skin Neoplasms Kidney Neoplasms Cell Transformation, Neoplastic Neoplastic Cells, Circulating Pleural Effusion, Malignant Bronchial Neoplasms Pleural Neoplasms Cholangiocarcinoma Bile Duct Neoplasms Carcinoma, Ductal, Breast Mesothelioma Glioblastoma Neuroblastoma Genetic Predisposition to Disease Lymphoma, Large B-Cell, Diffuse Carcinoma, Renal Cell Gallbladder Neoplasms Sarcoma

Chemicals and Drugs64

Tumor Markers, Biological Quinazolines Antineoplastic Agents Receptor, Epidermal Growth Factor Cisplatin Protein Kinase Inhibitors Vinblastine Deoxycytidine Paclitaxel Carboplatin Neoplasm Proteins Taxoids DNA, Neoplasm RNA, Messenger Guanine Receptor, erbB-2 Tumor Suppressor Protein p53 Glutamates Ki-67 Antigen Keratin-19 Antineoplastic Agents, Phytogenic Proto-Oncogene Proteins RNA, Small Interfering Biological Markers Tumor Suppressor Proteins MicroRNAs Antigens, Neoplasm Antibodies, Monoclonal, Humanized Fluorodeoxyglucose F18 ras Proteins Platinum Compounds Platinum Antimetabolites, Antineoplastic Antibodies, Monoclonal Vindesine Radiopharmaceuticals Receptors, Estrogen Vascular Endothelial Growth Factor A Etoposide RNA, Neoplasm Carcinoembryonic Antigen Inhibitor of Apoptosis Proteins Cadherins Proto-Oncogene Proteins c-met Oncogene Proteins, Fusion Receptor Protein-Tyrosine Kinases Ifosfamide Radiation-Sensitizing Agents Proto-Oncogene Proteins c-akt Pyrazoles Cyclooxygenase 2 Nuclear Proteins DNA-Binding Proteins Receptors, Progesterone Endonucleases Doxorubicin Proto-Oncogene Proteins c-bcl-2 Angiogenesis Inhibitors Death-Associated Protein Kinases Transcription Factors Pyridines Mitomycin Phosphopyruvate Hydratase PTEN Phosphohydrolase

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Prognosis Survival Analysis Survival Rate Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Immunohistochemistry Disease-Free Survival Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Neoplasm Staging Proportional Hazards Models Multivariate Analysis Predictive Value of Tests Combined Modality Therapy Prospective Studies Pneumonectomy Tissue Array Analysis Risk Factors Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Immunoenzyme Techniques Cohort Studies Tomography, X-Ray Computed Tumor Burden Chemotherapy, Adjuvant Neoplasm Grading Xenograft Model Antitumor Assays In Situ Hybridization, Fluorescence Molecular Targeted Therapy Drug Administration Schedule Risk Assessment Positron-Emission Tomography Blotting, Western Sensitivity and Specificity Oligonucleotide Array Sequence Analysis Clinical Trials as Topic Case-Control Studies Polymerase Chain Reaction Chi-Square Distribution Real-Time Polymerase Chain Reaction Palliative Care Clinical Trials, Phase III as Topic Severity of Illness Index Chemoradiotherapy Biopsy Individualized Medicine Radiotherapy Dosage Reproducibility of Results ROC Curve Randomized Controlled Trials as Topic Clinical Trials, Phase II as Topic Radiosurgery Multimodal Imaging Karnofsky Performance Status Radiotherapy, Adjuvant Neoadjuvant Therapy Remission Induction Gene Knockdown Techniques Lymph Node Excision Salvage Therapy Incidence Drug Screening Assays, Antitumor Radiotherapy Fatal Outcome Transplantation, Heterologous Neoplasm Transplantation Patient Selection Regression Analysis Biopsy, Needle Analysis of Variance Flow Cytometry Magnetic Resonance Imaging Registries Probability Infusions, Intravenous Clinical Trials, Phase I as Topic Statistics, Nonparametric Mediastinoscopy Maximum Tolerated Dose

Psychiatry and Psychology1

Phenomena and Processes42

Gene Expression Regulation, Neoplastic Time Factors Mutation Drug Resistance, Neoplasm Cell Proliferation Genes, erbB-1 Apoptosis DNA Methylation Signal Transduction Sensitivity and Specificity Gene Amplification Chi-Square Distribution Genes, p53 Up-Regulation Gene Expression Down-Regulation Genotype Cell Movement Cell Survival Dose-Response Relationship, Drug RNA Interference Polymorphism, Single Nucleotide Gene Dosage Promoter Regions, Genetic Genes, Tumor Suppressor Chromosome Aberrations Loss of Heterozygosity Genes, Neoplasm Epithelial-Mesenchymal Transition Drug Synergism Cell Growth Processes Phenotype Phosphorylation Chromosomes, Human, Pair 3 Probability Genes, erbB-2 Cell Cycle Gene Silencing Polymorphism, Genetic Genetic Predisposition to Disease Maximum Tolerated Dose Exons

Disciplines and Occupations3

Immunohistochemistry Individualized Medicine Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Incidence Fatal Outcome Registries

Named Groups2

Asian Continental Ancestry Group Infant, Newborn

Health Care37

Survival Analysis Survival Rate Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Disease-Free Survival Follow-Up Studies Proportional Hazards Models Multivariate Analysis Predictive Value of Tests Prospective Studies Risk Factors Cohort Studies Age Factors Risk Assessment Sensitivity and Specificity Clinical Trials as Topic Case-Control Studies Chi-Square Distribution Palliative Care Clinical Trials, Phase III as Topic Severity of Illness Index Reproducibility of Results ROC Curve Randomized Controlled Trials as Topic Clinical Trials, Phase II as Topic Karnofsky Performance Status Incidence Sex Factors Fatal Outcome Patient Selection Regression Analysis Analysis of Variance Registries Probability Clinical Trials, Phase I as Topic Statistics, Nonparametric

Geographicals2

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care Geographicals

Prognosis Survival Analysis Survival Rate Tumor Markers, Biological Treatment Outcome Adenocarcinoma Cell Line, Tumor Kaplan-Meier Estimate Retrospective Studies Immunohistochemistry Gene Expression Regulation, Neoplastic Quinazolines Disease-Free Survival Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Receptor, Epidermal Growth Factor Follow-Up Studies Carcinoma, Large Cell Carcinoma, Squamous Cell Cisplatin Lymphatic Metastasis Neoplasm Staging Proportional Hazards Models Disease Progression Multivariate Analysis Time Factors Predictive Value of Tests Protein Kinase Inhibitors Combined Modality Therapy Neoplasm Invasiveness Vinblastine Deoxycytidine Neoplasm Recurrence, Local Breast Neoplasms Prospective Studies Mutation Pneumonectomy Paclitaxel Drug Resistance, Neoplasm Carboplatin Tissue Array Analysis Cell Proliferation Carcinoma, Small Cell Risk Factors Reverse Transcriptase Polymerase Chain Reaction Adenocarcinoma, Bronchiolo-Alveolar Neoplasm Proteins Gene Expression Profiling Taxoids Brain Neoplasms Immunoenzyme Techniques Cohort Studies Genes, erbB-1 Tomography, X-Ray Computed DNA, Neoplasm Tumor Burden Apoptosis RNA, Messenger Mice, Nude Chemotherapy, Adjuvant Lung Neoplasms Neoplasm Grading DNA Methylation Guanine Xenograft Model Antitumor Assays Recurrence Tumor Cells, Cultured Receptor, erbB-2 Tumor Suppressor Protein p53 Age Factors In Situ Hybridization, Fluorescence Liver Neoplasms Glutamates Neoplasm Metastasis Molecular Targeted Therapy Carcinoma Ki-67 Antigen Drug Administration Schedule Risk Assessment Positron-Emission Tomography Blotting, Western Signal Transduction Mediastinum Sensitivity and Specificity Oligonucleotide Array Sequence Analysis Stomach Neoplasms Keratin-19 Gene Amplification Antineoplastic Agents, Phytogenic Proto-Oncogene Proteins Clinical Trials as Topic Case-Control Studies Lymph Nodes RNA, Small Interfering Biological Markers Colorectal Neoplasms Polymerase Chain Reaction Carcinoma, Hepatocellular Tumor Suppressor Proteins Neovascularization, Pathologic

No FAQ available that match "prognosis of nsclc"